Physician profile
Michael Owens
NPI 1700887981
$2,756.72
in general payments reported to CMS, 2019-2025
16 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $108 · 2021: $238 · 2022: $329 · 2023: $452 · 2024: $656 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $790.54 | 2020-2025 | |
| Aerin Medical INC. | $675.06 | 2022-2025 | |
| Optinose US, INC. | $314.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $251.22 | 2021-2025 | Nucala |
| Acclarent, INC | $250.74 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $173.25 | 2024-2025 | Dupixent |
| Medtronic, INC. | $72.85 | 2024-2025 | Stealthstation S8 Platform, Nuvent |
| Hikma Pharmaceuticals USA | $53.90 | 2023-2024 | Ryaltris |
| Smith+Nephew, INC. | $42.91 | 2019 | |
| Medtronic USA, INC. | $29.92 | 2019 | |
| Cook Medical LLC | $18.71 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.12 | 2020 | |
| Stryker Corporation | $17.39 | 2021 | |
| Aroa Biosurgery Incorporated | $16.31 | 2024 | |
| Integra Lifesciences Corporation | $16.19 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $15.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.